NeuraGen 3D Pilot Study

Digital Nerve Injury Clinical Trial

Official title:
An Open-Label, Multicenter, Pilot Study to Evaluate the Performance and Safety of NeuraGen® 3D Nerve Guide Matrix.

Status Terminated

Clinical Trial Summary

This is a 10-subject, 12-month follow-up, prospective, multi-center, open-label, single arm clinical trial designed to understand the initial performance characteristics and confirm the safety profile of the NeuraGen 3D Nerve Guide Matrix.

Clinical Trial Description

The NeuraGen® 3D Nerve Guide Matrix is indicated for the repair of peripheral nerve discontinuities where tension-free closure can be achieved by flexion of the digit or extremity. ;

Study Design

Related Conditions & MeSH terms

Digital Nerve Injury

Clinical Trial Details

NCT number	NCT05343143
Study type	Interventional
Source	Integra LifeSciences Corporation
Contact
Status	Terminated
Phase	N/A
Start date	May 15, 2022
Completion date	May 13, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05337917` - Digital Nerve Injury - a Case Control Study
Recruiting	`NCT04115982` - Vitamin D3 in Sensory Recovery After Digital NERVe Suture (D3NERV).	Phase 3
Completed	`NCT05269719` - Epidemiology of Digital Nerve Injuries in the Stockholm County
Active, not recruiting	`NCT04327154` - TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial	N/A
Recruiting	`NCT05536609` - Cast Or ePineural Suture for Digital Nerve Injuries - a Randomised Controlled Study	N/A